Key result
Patients with congestive heart failure demonstrated a maximal forearm blood flow response to isoproterenol comparable to normal subjects (8.0 vs 9.2 ml/100 ml/min; P=NS).
Why the study?
It is not known whether desensitization of peripheral beta-adrenoceptors accounts for impaired limb vasodilation in patients with congestive heart failure.
Does beta-adrenergic receptor stimulation with isoproterenol alter limb vasodilation in patients with congestive heart failure compared to normal subjects?
Observational (n=27)
Does beta-adrenergic receptor stimulation with isoproterenol alter limb vasodilation in patients with congestive heart failure compared to normal subjects?
Beta-adrenoceptor desensitization does not appear to occur in the limb vessels of patients with congestive heart failure, as forearm blood flow responses to isoproterenol are preserved.
Answers are grounded in this paper and cite their sources.
Preserved forearm vasodilator responses to isoproterenol in HF; supports intact peripheral beta-adrenergic signaling but leaves open tissue-specific desensitization mechanisms.
BACKGROUND In patients with congestive heart failure, the chronotropic and inotropic responses to beta-adrenergic agonists are reduced. It is not known whether desensitization of peripheral beta-adrenoceptors accounts for impaired limb vasodilation in these patients. Accordingly, we studied 14 normal subjects and 13 age-matched patients with congestive heart failure. METHODS AND RESULTS To distinguish vasodilation mediated by beta-adrenoceptors and adenylate cyclase from that mediated by stimulation of guanylate cyclase, each subject received intrabrachial artery infusions of isoproterenol (1-100 ng/min) and sodium nitroprusside (0.3-10 micrograms/min), respectively. Forearm blood flow was determined by venous occlusion plethysmography. Maximal vasodilative potential, determined during reactive hyperemia, was reduced in the patients with congestive heart failure. The maximal forearm blood flow response to isoproterenol was comparable in patients with heart failure and in normal subjects (8.0 +/- 1.1 versus 9.2 +/- 1.2 ml/100 ml of tissue/min, respectively, p = NS). Furthermore, the dose-response relation to isoproterenol was similar in both groups. Likewise, the forearm vasodilative response to sodium nitroprusside was preserved in the heart failure group. Plasma concentration of norepinephrine was higher in the patients with heart failure (436 +/- 34 versus 201 +/- 74 pg/ml, p less than 0.01). When both groups were considered, there was no correlation between norepinephrine levels and the maximal forearm blood flow response to isoproterenol (r = 0.10, p = NS). CONCLUSIONS We conclude that beta-adrenoceptor desensitization does not occur in the limb vessels of patients with congestive heart failure.
No takes yet. Share an insight, caveat, or question.
Creager et al. (1991) conducted an observational in Congestive heart failure (n=27). Congestive heart failure vs. Normal subjects was evaluated on Maximal forearm blood flow response to isoproterenol (ml/100 ml of tissue/min) (p=NS). Patients with congestive heart failure demonstrated a maximal forearm blood flow response to isoproterenol comparable to normal subjects (8.0 vs 9.2 ml/100 ml/min; P=NS).
Synapse has enriched 10 related papers. Consider them for comparative context: